Jenkins C D, Tuft S J, Sheraidah G, McHugh D A, Buckley R J
Moorfields Eye Hospital, London.
Br J Ophthalmol. 1996 Aug;80(8):685-8. doi: 10.1136/bjo.80.8.685.
The choice of a prophylactic antibiotic for cataract surgery is dependent on its antibacterial activity and tissue penetration. The influence of the route and timing of administration of cefuroxime on its intraocular concentrations was examined.
120 patients were recruited before cataract surgery into a prospective trial to compare the anterior chamber concentration of cefuroxime at a fixed time after administration by three routes. In a further 110 patients, the interval before sampling was varied in order to permit an examination of the kinetics of penetration. In another 10 patients, cefuroxime was given topically at the completion of surgery to assess the effect of a corneal wound on aqueous penetration. Cefuroxime concentrations were measured by high performance liquid chromatography on 0.2 ml samples of aqueous aspirated from the anterior chamber. Mean aqueous concentrations of cefuroxime for each group were compared using Student's t test.
After 25 mg cefuroxime, mean aqueous concentrations increased in the order forniceal (< 0.1 microgram/ml) < topical (0.18 microgram/ml) < subconjunctival (2.31 microgram/ml) when sampled 12-24 minutes after administration. Aqueous concentrations of cefuroxime reached a peak between 80 and 110 minutes after both forniceal and peribulbar injection but were still rising at this time after subconjunctival injection. Topical application of 12.5 mg cefuroxime to eyes with a 10 mm corneal wound resulted in a mean aqueous concentration of 9.34 micrograms/ml.
In the intact eye, only sub-conjunctival injection resulted in clinically significant aqueous concentrations of cefuroxime (> 1 microgram/ml) between 12 and 24 minutes after administration. For all routes, maximal aqueous concentrations were delayed by at least 80 minutes from administration. In the presence of a corneal wound, high aqueous levels of cefuroxime were rapidly attained after topical application.
白内障手术预防性抗生素的选择取决于其抗菌活性和组织穿透力。本研究检测了头孢呋辛给药途径和时间对其眼内浓度的影响。
120例白内障手术患者纳入前瞻性试验,比较三种给药途径给药后固定时间头孢呋辛在前房的浓度。另外110例患者,改变取样前的间隔时间以研究其穿透动力学。另有10例患者,在手术结束时局部应用头孢呋辛以评估角膜伤口对房水渗透的影响。通过高效液相色谱法测定从前房抽取的0.2 ml房水样本中头孢呋辛的浓度。采用学生t检验比较各组头孢呋辛的平均房水浓度。
给予25 mg头孢呋辛后,给药后12 - 24分钟取样时,平均房水浓度按穹窿部(<0.1微克/毫升)<局部(0.18微克/毫升)<结膜下(2.31微克/毫升)的顺序升高。穹窿部和球周注射后头孢呋辛的房水浓度在80至110分钟达到峰值,但结膜下注射后此时仍在上升。对有10 mm角膜伤口的眼睛局部应用12.5 mg头孢呋辛,平均房水浓度为9.34微克/毫升。
在完整眼中,仅结膜下注射在给药后12至24分钟可产生具有临床意义的头孢呋辛房水浓度(>1微克/毫升)。对于所有给药途径,最高房水浓度从给药起至少延迟80分钟。存在角膜伤口时,局部应用后可迅速达到较高的房水浓度。